- Home
- PRLD vs DIBS Comparison
PRLD vs DIBS Comparison
Compare PRLD & DIBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRLD | DIBS |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.0M | 194.7M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PRLD | DIBS |
|---|---|---|
| Price | $4.51 | $4.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $5.67 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 506.5K | 171.2K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.21 | 22.45 |
| EPS | N/A | ★ N/A |
| Revenue | $12,140,000.00 | ★ $89,620,000.00 |
| Revenue This Year | $320.10 | $3.12 |
| Revenue Next Year | $100.00 | $1.72 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 73.43 | 1.54 |
| 52 Week Low | $0.75 | $2.35 |
| 52 Week High | $5.54 | $6.62 |
Technical Indicators
Market Signals| Indicator | PRLD | DIBS |
|---|---|---|
| Relative Strength Index (RSI) | 49.50 | 36.33 |
| Support Level | $1.09 | $4.38 |
| Resistance Level | $5.43 | $5.74 |
| Average True Range (ATR) | 0.53 | 0.33 |
| MACD | -0.08 | -0.01 |
| Stochastic Oscillator | 31.37 | 48.87 |
Price Performance
Historical ComparisonAbout PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The company has a single reportable and operating segment that contains one reporting unit, which consists of the company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.